These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24930566)

  • 1. In vitro approaches to pharmacological screening in the field of atopic dermatitis.
    Castex-Rizzi N; Galliano MF; Aries MF; Hernandez-Pigeon H; Vaissiere C; Delga H; Caruana A; Carrasco C; Lévêque M; Duplan H; Bessou-Touya S
    Br J Dermatol; 2014 Jul; 170 Suppl 1():12-8. PubMed ID: 24930566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics in atopic dermatitis.
    Taïeb A; Seneschal J; Mossalayi MD
    J Dtsch Dermatol Ges; 2012 Mar; 10(3):174-8. PubMed ID: 21812930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pimecrolimus on innate immunity in subjects with atopic dermatitis: a double-blind, randomized, vehicle-controlled study.
    Afshar M; Kotol P; Miller J; Gallo R; Hata T
    Br J Dermatol; 2013 Feb; 168(2):426-8. PubMed ID: 22577776
    [No Abstract]   [Full Text] [Related]  

  • 4. [Triderm in the treatment of atopic dermatitis].
    Kaliuzhnaia DD
    Voen Med Zh; 1999 Feb; 320(2):53-5. PubMed ID: 10330896
    [No Abstract]   [Full Text] [Related]  

  • 5. Atopic dermatitis: the skin barrier and beyond.
    Tsakok T; Woolf R; Smith CH; Weidinger S; Flohr C
    Br J Dermatol; 2019 Mar; 180(3):464-474. PubMed ID: 29969827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atopic dermatitis.
    Ghazvini P; Pagan LC; Rutledge TK; Goodman HS
    J Pharm Pract; 2010 Apr; 23(2):110-6. PubMed ID: 21507803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus.
    Tavakolpour S
    Dermatol Ther; 2016 Sep; 29(5):299. PubMed ID: 26800435
    [No Abstract]   [Full Text] [Related]  

  • 8. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis.
    Jensen JM; Pfeiffer S; Witt M; Bräutigam M; Neumann C; Weichenthal M; Schwarz T; Fölster-Holst R; Proksch E
    J Allergy Clin Immunol; 2009 May; 123(5):1124-33. PubMed ID: 19410693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.
    Olivry T; DeBoer DJ; Favrot C; Jackson HA; Mueller RS; Nuttall T; Prélaud P;
    Vet Dermatol; 2010 Jun; 21(3):233-48. PubMed ID: 20456716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naphthalene in the treatment of patients with atopic dermatitis.
    Smeh-Skrbin A; Dobrić I; Krnjević-Pezić G; Vrzogić P
    Acta Dermatovenerol Croat; 2007; 15(1):15-9. PubMed ID: 17433174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atopic dermatitis in children: management of pruritus.
    Blume-Peytavi U; Metz M
    J Eur Acad Dermatol Venereol; 2012 Nov; 26 Suppl 6():2-8. PubMed ID: 23067431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atopic dermatitis in infants and children. Diagnosis and management.
    Keipert JA
    Aust Fam Physician; 1985 Dec; 14(12):1370-3. PubMed ID: 3833182
    [No Abstract]   [Full Text] [Related]  

  • 13. [Not Available].
    Nguyen T; Castex-Rizzi N; Redoulès D
    Ann Dermatol Venereol; 2017 Jan; 144 Suppl 1():S42-S49. PubMed ID: 29221590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in pruritus in children with atopic dermatitis using pimecrolimus cream 1%.
    Fowler J; Johnson A; Chen M; Abrams K
    Cutis; 2007 Jan; 79(1):65-72. PubMed ID: 17330625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atopic dermatitis: systemic immunosuppressive therapy.
    Akhavan A; Rudikoff D
    Semin Cutan Med Surg; 2008 Jun; 27(2):151-5. PubMed ID: 18620137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical treatment for atopic dermatitis in the 21st century.
    Johnson SM; Kincannon JM; Dudney DL;
    J Ark Med Soc; 2004 Sep; 101(3):86-90. PubMed ID: 15384500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate.
    Blume-Peytavi U; Wahn U
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):508-15. PubMed ID: 21492244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colloidal oatmeal formulations as adjunct treatments in atopic dermatitis.
    Fowler JF; Nebus J; Wallo W; Eichenfield LF
    J Drugs Dermatol; 2012 Jul; 11(7):804-7. PubMed ID: 22777219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights in the pathogenesis of atopic dermatitis.
    Ong PY
    Pediatr Res; 2014 Jan; 75(1-2):171-5. PubMed ID: 24192701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab for the treatment of atopic dermatitis.
    Fernández-Antón Martínez MC; Leis-Dosil V; Alfageme-Roldán F; Paravisini A; Sánchez-Ramón S; Suárez Fernández R
    Actas Dermosifiliogr; 2012 Sep; 103(7):624-8. PubMed ID: 22056257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.